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Abstract: A substantial body of literature has demon-
strated that the nutritional environment an individual 
experiences before birth or in early infancy is a key deter-
minant of their health outcomes across the life course. 
This concept, the developmental origins of health and 
disease (DOHaD) hypothesis, was initially focused on the 
adverse consequences of exposure to a suboptimal nutri-
ent supply and provided evidence that maternal under-
nutrition, fetal growth restriction, and low birth weight 
were associated with heightened risk of central adipos-
ity, insulin resistance, and cardiovascular disease. More 
recently, the epidemic rise in the incidence of maternal 
obesity has seen the attention of the DOHaD field turn 
toward identifying the impact on the offspring of expo-
sure to an excess nutrient supply in early life. The asso-
ciation between maternal obesity and increased risk of 
obesity in the offspring has been documented in human 
populations worldwide, and animal models have pro-
vided critical insights into the biological mechanisms 
that drive this relationship. This review will discuss the 
important roles that programming of the adipocyte and 
programming of the central neural networks which con-
trol appetite and reward play in the early life program-
ming of metabolic disease by maternal overnutrition. It 
will also highlight the important research gaps and chal-
lenges that remain to be addressed and provide a per-
sonal perspective on where the field should be heading in 
the coming 5–10 years.
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Introduction
There is a substantial body of literature, which has dem-
onstrated that the nutritional environment an individual 
experiences before birth or in early infancy is a key deter-
minant of their health outcomes across the life course [1, 2]. 
The developmental origins of health and disease (DOHaD) 
hypothesis was initially focused largely on the adverse 
consequences of exposure to a suboptimal nutrient supply 
and provided compelling evidence that maternal under-
nutrition, fetal growth restriction, and low birth weight 
were associated with heightened risk of central adiposity, 
insulin resistance, and cardiovascular disease in later life 
[3]. More recently, however, the attention of the DOHaD 
field has increasingly turned toward identifying the impact 
on offspring of exposure to an excess nutrient supply in 
early life. This has clear relevance in the context of the 
obesity epidemic that is currently affecting both deve-
loped and developing nations worldwide and the result-
ing increase in the number of women entering pregnancy 
overweight or obese coupled with the rise in consumption 
of palatable (energy-dense, nutrient-poor) foods [4–6].
The association between maternal and childhood 
obesity has been documented in human populations 
worldwide and widely replicated in animal models. In 
addition to supporting the epidemiological and clinical 
data, the work in animal models has provided insights into 
the biological mechanisms, which drive this relationship.
The purpose of the current review is to examine the 
evidence linking maternal overnutrition to the early life 
origins of obesity and, thereby, define our current under-
standing of the biological mechanisms through which 
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exposure to excess nutrients before birth predisposes 
individuals to obesity in later life. It will also highlight the 
important research gaps and challenges that remain to be 
addressed and provide our perspective on where the field 
should be heading in the coming 5–10 years.
Maternal obesity: a growing 
obstetric challenge
The worldwide epidemic of obesity has affected children 
and adults and has led to a corresponding increase in the 
number of women entering pregnancy with a body mass 
index (BMI) that places them in the overweight or obese 
category. In a recent study by Dodd and colleagues, it 
was reported that over 50% of women in South Australia 
were overweight or obese when presenting for their first 
antenatal appointment [4], and similar figures have been 
reported in the US [6].
Maternal obesity is undesirable for a host of reasons 
related to maternal health, pregnancy outcomes, and the 
short- and long-term health of the child. It is well docu-
mented that overweight and obese mothers are at an 
increased risk of a number of pregnancy complications, 
including gestational diabetes, preeclampsia, fetal over-
growth, and macrosomia. The infants born to these women 
are also more at risk of neonatal morbidities, including 
neonatal hypoglycemia, jaundice, shoulder dystosia, and 
unexplained neonatal death [6].
In addition to these short-term clinical complications, 
it is now clear that maternal overweight and obesity are 
also associated with a significant increase in the risk of 
obesity, diabetes and cardiovascular diseases in the child 
[1, 7]. The increasing prevalence of overweight and obesity 
among pregnant women has, therefore, led to the estab-
lishment of an intergenerational cycle of obesity and 
metabolic disease, whereby heavier mothers give birth to 
heavier infants who go on to be fatter and less metaboli-
cally healthy in later life.
Consequences of maternal obesity 
for the mother
The developing fetus relies exclusively on the mother to 
supply all the nutritional factors necessary for achiev-
ing optimal growth and development [8]. Consequently, 
any perturbation which impacts negatively on maternal 
health, is likely to have negative effects on the developing 
fetus. While some nutrients (e.g., glucose) are able to 
readily cross the placenta and are transmitted to the fetus 
down a concentration gradient, the majority of nutri-
ents are transferred via active transport mechanisms or 
undergo extensive metabolism/conversion before reach-
ing the fetus [8]. This suggests that the effects of overnu-
trition on the development of the offspring may not be 
mediated directly by the nutrients, themselves, but by 
the impact that this diet has on the metabolic/hormonal 
status of the mother.
Both human and animal data provide clear evidence 
of substantial alterations to maternal metabolism in 
response to maternal obesity and/or maternal overnu-
trition. In humans, maternal overweight and obesity is 
typically associated with reduced insulin sensitivity and 
an increased risk of the mother developing gestational 
diabetes mellitus [6]. Even when overt gestational dia-
betes does not develop, these women still typically have 
lower insulin sensitivity and glucose tolerance compared 
to normal-weight women, which translates into elevated 
maternal glucose concentrations and exposure of the 
developing fetus to an increased glucose supply [9, 10]. 
Plasma triglyceride concentrations are also elevated in 
obese compared to lean pregnant women, and evidence 
from nonhuman primates suggests that these triglyc-
erides readily cross the placenta and are deposited in 
fetal tissues, inducing lipotoxicity [11]. Maternal obesity 
in humans and high-fat diets in pregnant rodents also 
result in a heightened inflammatory state in the mothers – 
and these inflammatory mediators can either be trans-
ferred to the fetus or affect the ability of the placenta to 
transfer other nutrients/oxygen from the maternal to fetal 
circulation [12, 13]. Clinical studies have reported that 
obese women (particularly those with BMIs of  > 35) have 
an increased risk of placental dysfunction, which may 
explain the clinical observation that obese women, partic-
ular those with morbid obesity, are at an increased risk of 
stillbirth, fetal growth restriction, and prelabor caesarean 
delivery [14]. Disturbances to uteroplacental hemodynam-
ics and an increased incidence of stillbirth has also been 
reported in nonhuman primates maintained on high-fat 
diets during their pregnancy [15].
The importance of maternal nutrition 
for the programming of obesity
Given that the nutrients in the maternal circulation provide 
the sole source of nutrients for the developing fetus, it is 
not surprising that the maternal diet during pregnancy 
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plays a major role in determining the short- and long-term 
developmental outcomes of the offspring.
The impact of maternal overnutrition on the fetus 
and neonate in humans is, perhaps, most clearly demon-
strated by studies of infants of diabetic mothers [16, 17]. 
As glucose is transferred across the placenta by passive 
transfer down a concentration gradient, high concen-
trations of glucose in the maternal circulation result in 
exposure of the fetus to an increased glucose supply [18]. 
Metzger was the first to develop the “fuel-mediated tera-
togenesis” model, in which fetal hyperglycemia results in 
increased release of insulin by the fetal pancreas, leading 
to fetal hyperinsulinemia [19]. The increase in fetal insulin 
concentrations, in turn, results in increased uptake of 
glucose and amino acids into insulin-sensitive tissues, in 
particular, the adipose tissue, ultimately leading to the 
fetal overgrowth and excess accumulation of fat mass 
that is frequently observed in infants of diabetic mothers 
at delivery. In addition, these infants were also found 
to be at an increased risk of obesity in later life [16, 17]. 
Subsequent studies revealed that, even in the absence 
of overt maternal diabetes, maternal insulin resistance 
or even mild impairments to maternal glucose tolerance 
are also associated with increased fat mass in the neonate 
and an increased risk of obesity and diabetes in the off-
spring. Indeed, clinical studies revealed a close asso-
ciation between glucose concentrations in the umbilical 
cord blood at delivery and neonatal fat mass, implicating 
glucose as a key driver of excess intrauterine fat deposi-
tion [10].
The role of maternal glucose as a driver of fetal 
programming has been confirmed in animal studies, 
in which maternal diabetes has been induced by treat-
ment with streptozotocin prior to pregnancy [20] or 
maternal hyperglycemia induced by maternal overfeed-
ing [21, 22]. In the sheep, direct infusion of glucose to 
the fetus also results in significant increases in fetal fat 
deposition in utero [23, 24]. In addition, animal studies 
have demonstrated that increased maternal nutrient 
intake, in the form of either an increase in total caloric 
intake or specific increases in the consumption of satu-
rated fat and/or sugar (semisynthetic or cafeteria diets) 
is associated with a significant increase in the inci-
dence of obesity and insulin resistance in the offspring 
after weaning [25]. In addition to supporting clinical 
and epidemiological findings, these animal studies of 
developmental programming have enabled researchers 
to explore the biological mechanisms which underlie 
the relationship between exposure to an elevated nutri-




















Figure 1 Potential mechanisms proposed to underlie the develop-
ment of obesity after exposure to maternal overnutrition or maternal 
obesity before birth.
Targets of nutritional programming
The relationship between maternal overnutrition during 
pregnancy and lactation with the programming of increased 
obesity risk in the offspring has led to a large number of 
studies focused on the underlying biological mechanisms. 
These studies have established that exposure of the fetus/
neonate to an elevated nutrient supply either in the form of 
glucose, fat, or global caloric excess during critical develop-
mental windows results in permanent alterations in the struc-
ture and function of key systems involved in the regulation 
of energy balance and metabolic control [25–28] (Figure 1). 
There is an ever-increasing list of physiological systems 
whose development is impacted by exposure to increased 
nutrition; however, this review will focus principally on the 
role of the adipocyte and the central neural networks which 
regulate appetite and reward in metabolic programming.
Adipose tissue
The fat cell, or adipocyte, has been implicated as a key 
target of developmental programming. Indeed, we have 
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previously suggested that the increased incidence of type 
2 diabetes and cardiovascular disease associated with 
prenatal exposure to excess nutrition is secondary to the 
increased accumulation of fat mass, rather than the direct 
effects of the overnutrition on insulin signaling pathways 
or the cardiovascular system itself [27]. This hypothesis 
suggests that the programming of the adipocyte is the 
primary event that drives the early life programming 
of obesity in offspring exposed to an increased nutrient 
supply before birth.
There is certainly evidence from both small and large 
animal models that exposure to an increased supply of 
glucose and lipids during critical periods in the devel-
opment of adipose depots is associated with a precocial 
upregulation of lipogenic genes within fat depots [29, 30]. 
Importantly, this is associated with a persistent increase 
in the capacity of adipocytes for lipid storage, which 
renders the individual more susceptible to fat storage in 
postnatal life [22, 28]. Studies in both pigs and sheep, in 
which fat cell development begins before birth, have dem-
onstrated that maternal hyperglycemia is associated with 
an increase in the mRNA expression and/or activity of 
important lipogenic mediators in the adipocyte.
In pigs, Kasser and colleagues reported that induc-
tion of gestational diabetes in the pregnant sow increased 
adipose tissue thickness in fetuses at 112 days gestation via 
an upregulation of lipogeneic activity in fetal fat depots 
[28]. Similarly, in studies of an obesity-prone breed of pig 
by Hausman and colleagues, pre-obese fetuses exhib-
ited increased fat mass, increased adipocyte size, and 
increased lipogenic activity in their fat depots prior to the 
onset of obesity in postnatal life [31]. In the sheep, feeding 
ewes ~55% above their maintenance energy requirements 
during the final 35 days of gestation was associated with 
significant increases in maternal and fetal glucose con-
centrations [21]. Importantly, fetuses of overfed ewes 
exhibited an increased expression of the key lipogenic 
transcription factor peroxisome proliferator activated 
receptor gamma (PPARγ) in the perirenal fat depot in late 
gestation [29], and the lambs exposed to this intrauterine 
environment exhibited an increased fat mass by the end 
of the first month of life [22]. An interesting observation 
in these sheep studies was that the increases in PPARγ 
expression in the fetus were present in the perirenal 
adipose tissue, the only dissectible fat depot in the fetal 
sheep before birth, whereas it was subcutaneous fat mass 
that was increased to the greatest extent in the lambs of 
well-fed ewes at 1 month of age [22]. This implies, there-
fore, that the prenatal nutritional environment can act to 
program preadipocytes within the subcutaneous depot 
and/or that signals from the perirenal depot influence the 
development of other fat depots in early life. The concept 
of cross-talk is well explored in other organ systems, but 
the notion of one fat depot directing the development of 
another has yet to be empirically demonstrated.
Taken together, studies in large animal models 
provide clear evidence of the acute sensitivity of the devel-
oping adipocyte to the early nutritional environment. The 
studies in large animal models are more readily translata-
ble to the human context than studies in rodents, as there 
is limited development of adipose tissue before birth in 
rats and mice. Nevertheless, rodent studies provide a large 
body of support for the programming of the adipocyte by 
the nutritional environment experienced by the offspring 
during suckling, the major period of fat cell development 
[32, 33].
Appetite regulation
There is an extensive literature that has described the 
relationship between maternal/infant overnutrition and 
increased food intake in the offspring, which is driven 
by altered development of the neuronal pathways, which 
regulate appetite [22, 34, 35] (Figure 2).
The concept that adult appetite could be influ-












Figure 2 Summary of the proposed pathways through which 
maternal overnutrition results in dysregulation of appetite control in 
the offspring.
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was established as early the late 1970s by Oscai and col-
leagues, who showed that the amount of food that rats 
consumed as adults was directly related to the amount of 
food they consumed in the early postweaning period [36]. 
It was not until almost 30  years later, however, that the 
work of Plagemann and colleagues provided insights into 
the underlying biological mechanisms. These studies pro-
vided the first evidence for the programming of the central 
neural network for appetite regulation, by demonstrat-
ing that early postnatal overnutrition induced by rearing 
animals in small litters was associated with alterations 
in the architecture of the key hypothalamic nuclei within 
the appetite-regulating network [34, 37, 38] and altered 
expression of the key neuropeptides implicated in appe-
tite regulation [34, 39]. These structural and functional 
changes persisted throughout the life of these animals, 
and as a consequence, these animals exhibited persis-
tent hyperphagia leading to weight gain and increased fat 
mass. Postnatal hyperphagia is also seen in offspring of 
rats fed a high-fat diet during pregnancy and lactation; 
these offspring consume more energy postweaning and 
have a higher body weight compared to the control off-
spring when weaned onto either a standard rat chow [35] 
or high-fat diet [40].
Studies in large animal models, in which the major 
period of development of the appetite-signaling pathways 
occurs before birth, as in the human, provide additional 
support for the programming of appetitive structures. 
Exposure to maternal overnutrition in late gestation was 
shown to be associated with an increased appetite in the 
lambs during the first 3 weeks after birth [22]. Importantly, 
lambs of well-fed ewes exhibited a reduced capacity to 
upregulate the expression of the appetite-inhibiting neu-
ropeptide, cocaine- and amphetamine-regulated tran-
script (CART), in response to increases in their fat mass 
[22], indicative of a dysregulation of appetite control. This 
suggests, therefore, that lambs exposed to an increased 
nutrient supply before birth do not appropriately switch 
off their appetite when satiated thus rendering them more 
prone to overeating and weight gain.
While the mechanisms that lead to the early pro-
gramming of the appetite-regulating pathway are still 
unclear, two key hormones, insulin and leptin, which are 
known to be critical for the regulation of energy balance 
in adults, appear to play an important role. Plagemann’s 
group showed in rodent studies that the effects of postna-
tal overnutrition could be replicated by prenatal hyperin-
sulinemia, which led to the conclusion that insulin was 
the key factor responsible for mediating the structural 
and functional changes which were observed in postna-
tally overnourished offspring [41]. In addition to increases 
in circulating insulin, periods of overnutrition are also 
associated with increased concentrations of the adipo-
cyte-derived hormone leptin, and perinatal exposure 
to either insufficient or excessive leptin concentrations 
can also alter the development of the neural circuitry in 
the appetite-regulating network [42]. In 2004, Sebastian 
Bouret and Richard Simerly performed an elegant series 
of studies using the anterograde tracer DiI, showing 
that leptin-deficient ob/ob mice had a reduced density 
of neuronal connections linking the arcuate nucleus to 
other hypothalamic nuclei involved in the regulation of 
appetite, suggesting that leptin is required for the normal 
development of connections of the hypothalamic appe-
tite-regulating circuits. This mechanism was further sup-
ported when this phenotype was subsequently rescued 
by the administration of exogenous leptin in the immedi-
ate postnatal period, when the appetitive structures were 
still developing, but the same treatment was not effec-
tive when applied in adulthood [43, 44]. The importance 
of leptin in the development of appetitive connections 
within the hypothalamus was further confirmed by the 
addition of leptin to hypothalamic explants, which was 
shown to promote neurite outgrowth [43]. Therefore, the 
levels of insulin and leptin in the circulation during the 
development of neural circuits have the potential to per-
manently alter the structure, and therefore function, of 
these networks.
Reward pathways
In addition to the programming of food intake overall, there 
is a growing body of evidence that early nutritional expo-
sures also have the capacity for programming food prefer-
ences. Work from our group and others has shown that 
exposure to maternal diets dominated by palatable foods 
before birth and in early infancy shifts food preferences 
in the offspring toward an increased “liking” for high-fat 
and high-sugar foods [40, 45]. In our studies, we demon-
strated a specific preference for high-fat foods in offspring 
of rat dams fed a cafeteria junk food diet during preg-
nancy and lactation, which persists from weaning until at 
least 3 months of age in both males and females [45]. The 
precise mechanisms through which this programming 
of food preferences occurs remain poorly understood; 
however, the results of recent studies have implicated the 
programming of the central neural network, which regu-
lates motivation and reward as playing a central role [40, 
46] (Figure 3).
Palatable foods, i.e., those with high levels of satu-
rated fat and simple sugars, have been described as 
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natural rewards on the basis of their ability to activate the 
same central reward circuits as those recruited by illicit 
drugs and alcohol [47]. Thus, the consumption of high-fat 
and/or high-sugar diets in rats stimulates the release of 
dopamine and opioids within the central reward circuitry, 
which are responsible for eliciting the pleasurable sensa-
tion characteristic of rewarding substances [48]. There is 
also evidence suggesting that prolonged intake of a palat-
able diet, or sucrose or fat alone, produces similar altera-
tions in gene expression in the reward pathway as seen in 
rats addicted to cocaine, alcohol, or nicotine [49, 50]. This 
altered pattern of gene expression reduces the sensitiv-
ity of the reward pathway and drives the animal to obtain 
increasing quantity of the drug (or food) to maintain the 
same intensity of the resulting “high” [51].
It is well documented that mothers who consume 
illicit substances during their pregnancy give birth to 
infants who are addicted to this same substance at birth 
and who are more susceptible to other forms of addiction 
in later life [52]. Both human and animal studies have 
also shown that prenatal exposure to ethanol predisposes 
individuals not only to later ethanol dependence but also 
to other types of addiction [53, 54], and mice exposed to 
cocaine before birth exhibit an increased susceptibility to 
ethanol and cocaine addiction [55].
There is now increasing evidence from animal studies 
that prenatal exposure to high-fat, high-sugar diets is asso-











Figure 3 Summary of the mechanisms through which excessive 
maternal intake of palatable diets program food preferences in the 
offspring via programming of the central reward pathway.
the central reward circuits. Naef and colleagues investi-
gated the effect of feeding rat dams a high-saturated fat 
diet during the last week of gestation and throughout 
lactation on dopamine function in the key nuclei of the 
reward system and found that offspring of high fat-fed 
dams exhibited increased dopamine content in the 
nucleus accumbens and reduced sensitivity to stimulation 
by amphetamines, suggesting a permanent alteration to 
the function of the reward system [56]. Similarly, Vucetic 
and colleagues found that offspring of mice fed a high-fat 
diet during pregnancy had an increased preference for 
sucrose and fat, which was accompanied by higher levels 
of endogenous opioids and increased expression of the 
μ-opioid receptor [57]. As the opioid system is known to 
have an important role in promoting the intake of palata-
ble foods in adults, this could explain the increased prefer-
ence for sucrose and fat displayed by these offspring. The 
involvement of the opioid system in the programming of 
food intake and preference is supported by recent studies 
in our laboratory, in which we found that the expression of 
the μ-opioid receptor in a key region of the central reward 
system, the ventral tegmental area, was lower at weaning 
in offspring exposed to a maternal palatable diet before 
birth and during the suckling period [58]. Importantly, we 
also demonstrated that this had functional consequences 
for the regulation of opioid signaling in these offspring, 
since those offspring exposed to the palatable diet in early 
life were less sensitive to the effect of the μ-opioid recep-
tor antagonist, naloxone, in suppressing palatable food 
intake in the immediate postweaning period [58].
In addition to the opioid system, there is also evidence 
implicating the dopamine system in the early life pro-
gramming of food preferences. In their study, Vucetic and 
colleagues showed that the expression of the dopamine 
active transporter, which is responsible for the reuptake of 
dopamine from the synapse into the presynaptic neuron, 
was significantly increased, and dopamine receptors, D1 
and D2, were significantly downregulated in the offspring 
of mice fed a high-fat diet during pregnancy [57]. This is 
similar to results from our laboratory, in which we demon-
strated that offspring of dams fed a cafeteria diet during 
pregnancy and lactation exhibited an increased expres-
sion of the dopamine active transporter in the central 
reward system at 3 months of age [45]. These alterations 
within the dopamine-signaling pathway are consistent 
with hyposensitivity within the dopamine system that 
could drive further drug (i.e., food)-seeking behavior. This 
reduced sensitivity of the dopamine system has also been 
observed in mice that were exposed to a short period of 
high-fat feeding early in life, which also exhibited a strong 
preference toward high-fat foods in adult life [59].
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Can programming be reversed? New 
insights into the critical windows
As illustrated in the preceding paragraphs, a compelling 
series of experimental animal studies have demonstrated 
that maternal overnutrition impacts on the development 
of the adipocyte and neural pathways, and these changes 
serve to predispose the offspring to obesity and metabolic 
disease through the life course. The evidence for the pro-
gramming of obesity and metabolic disease by early life 
nutrition has increasingly led to the question of the extent 
to which these effects can be reversed by interventions, 
which are applied in postnatal life.
A number of studies in rodents have suggested that 
programming of the neural network for appetite regula-
tion and food preferences persist even when offspring 
are fed on nutritionally balanced diets from weaning to 
adulthood [35, 60]. However, other studies have suggested 
that there may be the potential to overcome at least some 
of the adverse effects of perinatal overnutrition through 
nutritional interventions applied in postnatal life. In 
one study, Velkovka and colleagues examined the effect 
of early postnatal overnutrition, induced by small-litter 
weaning, on blood pressure, hypothalamic expression of 
the appetite-stimulating neuropeptide NPY, and adiposity 
markers. Their key finding was that the negative meta-
bolic effects associated with early postnatal overnutrition 
could be largely overridden by providing a nutritionally 
balanced diet after weaning [61].
In a recent study, we set out to determine whether pro-
viding rodent offspring that had been exposed to a mater-
nal palatable diet before birth and during the suckling 
period with a standard rodent feed after weaning could 
mitigate the impact of the palatable diet on food prefer-
ences and gene expression in the reward system of the 
offspring. The key finding of this study was that providing 
offspring with a nutritionally balanced chow for 3 months 
after weaning was sufficient to overcome the effects of the 
perinatal diet on food preferences and the reward system 
in male, but not female, offspring [62]. However, while 
providing offspring with a nutritionally balanced diet 
for 3 weeks after weaning (the equivalent of consuming 
such a diet from weaning to adolescence) initially normal-
ized fat mass and food intake, both male and female off-
spring exhibited a higher energy consumption and gained 
more weight than the control offspring when their access 
to a palatable diet was reinstated, suggesting that the 
increased preference for the palatable diet was retained 
[62]. This adds to the growing body of evidence suggesting 
that the programming effects of perinatal overnutrition 
cannot be readily overcome by interventions applied later 
in life, and that while the phenotype can be controlled, 
an underlying susceptibility to metabolic challenges 
remains. Consequently, the key to breaking the intergen-
erational cycle of obesity is likely to rely more so on pre-
vention through improved nutrition in the mother and 
infant, rather than trying to correct these changes once 
they have occurred.
Maternal nutrition to optimize 
offspring outcomes: a major 
research challenge
If we accept that optimizing the maternal nutritional 
environment offers the greatest potential for improving 
the long-term metabolic health of the offspring, then, 
it stands to reason that identifying the dietary factors 
which are the key drivers of developmental program-
ming is of paramount importance in designing effec-
tive interventions. However, despite this realization, it 
remains unclear which components of the maternal diet 
are the most significant drivers of developmental pro-
gramming. The majority of animal models of maternal 
obesity involved providing pregnant and lactating rats 
with diets that contain high amounts of dietary fat (up to 
60% energy). While these studies have consistently dem-
onstrated that these high-fat diets are associated with 
a myriad of adverse effects on the mother and her off-
spring, including obesity, insulin resistance, endothelial 
dysfunction, and hyperphagia to name a few [63, 64], it 
is difficult to relate these findings to human diets, where 
fat intake even in obese individuals is significantly lower 
[65]. In addition, most “high-fat” diets are also high in 
calories, which make it impossible to separate the effects 
of consuming high amounts of fat from those of consum-
ing excess energy overall.
Moreover, even in those studies that have attempted 
to isolate the contribution of fat and calories, there are 
conflicting findings. In both rodents and sheep, increas-
ing the total energy intake in the absence of increased 
fat intake has been associated with increased fat mass 
and insulin resistance in the offspring [22]. One inter-
pretation of these findings is that excessive calorie 
intake in pregnancy is associated with an increased pre-
disposition to obesity and poor metabolic outcomes in 
the offspring, independent of the level of fat. However, 
other studies have suggested that dietary composition, 
in particular the fat content of the diet, is the most 
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important factor in developmental programming [64]. 
Thus, the role of macronutrient balance (particularly 
the ratio of fat to other dietary components) compared to 
total energy intake in metabolic programming remains 
uncertain.
In addition to the total amount of fat in the diet, 
there is increasing human and animal evidence that the 
relative proportion of saturated, monounsaturated, and 
polyunsaturated fat (PUFA) in the diet has important 
implications for the programming of metabolic disease 
[66, 67]. The majority of “high-fat” rodent diets have 
contained high levels of saturated fat, in line with the 
prevailing view that the saturates are the “bad guys” 
in relation to metabolic health [63]. These studies have 
certainly provided evidence that very high levels of sat-
urated fat intake (often in excess of 30% energy) have 
negative effects on metabolic outcomes in the offspring, 
including increased body fat mass, increased appetite, 
insulin resistance, and dyslipidemia [63, 64]. However, 
the role of saturated fat as the key driver of the intergen-
erational cycle of obesity in humans is difficult to recon-
cile with data from human populations in which obesity 
is increasing, but the intake of saturated fat has actu-
ally declined in recent decades [65]. Importantly, animal 
and human studies have demonstrated that increasing 
maternal PUFA intake, in the absence of high intake of 
saturates, also results in an increased fat mass in the off-
spring [68].
To complicate things further, the two classes of 
PUFA, the ω-6 and the ω-3, are not equipotent in promot-
ing adipose tissue deposition and have different effects 
on the metabolic outcomes of the offspring [66, 67]. In 
mice, chronic exposure over four generations to a diet 
with a high ω-6 PUFA content (comparable to that in the 
typical Western diet) was sufficient to trigger a gradual 
transgenerational enhancement of fat mass [69]. In 
another study, offspring of mice fed on high-ω-6 PUFA 
diets were 40% heavier from 1 week after weaning than 
those fed on a high-fat diet containing a mixture of ω-6 
and ω-3 PUFA, despite no difference in the total fat or 
calorie intake of the dams [66]. There are also human 
data supporting a relationship between maternal ω-6 
PUFA intake and offspring fat mass, including a recent 
study of 293 women in the UK, which reported that mater-
nal plasma ω-6 PUFA concentrations positively predicted 
offspring fat mass at 4 and 6 years of age [70]. Collectively, 
these findings have led to suggestions that the increase 
in the ω-6 PUFA content of the typical Western diet and, 
therefore in the diets of pregnant and lactating women, 
in recent decades, may be contributing to the increased 
prevalence of obesity and metabolic disease [71, 72]. 
Conversely, some animal and human studies have shown 
that increasing maternal ω-3 PUFA intake during preg-
nancy and lactation can actually reduce body fat mass 
in the offspring [73]. However, a systematic review of this 
research area indicates that the data is conflicting and 
provides a limited basis for drawing robust conclusions 
[68, 74]. Indeed, we have recently shown in our labora-
tory that maternal ω-3 PUFA supplementation (without 
any change in maternal energy intake) in rats was associ-
ated with a higher relative body fat mass in the offspring 
at 6 weeks of age [68].
Taken together, these data provide evidence of the 
complexity of the relationship that exists between the 
maternal diet and offspring health and highlight the 
need for studies that focus specifically on defining the 
separate and synergistic contributions of different dietary 
components to the programming of metabolic health and 
disease.
Expert opinion and outlook
The DOHaD is a relatively new field of research, and 
studies into the impact of maternal obesity/maternal over-
nutrition on the offspring have only appeared to any sig-
nificant extent in the last 10–15 years.
After initial resistance from clinicians, the concept 
that the nutritional environment in early life has critical 
relevance for the life-long health of the individual has now 
gained much wider acceptance, evidenced by a reference 
to the DOHaD hypothesis in the 2013 Australian Dietary 
Guidelines recently released by the National Health 
and Medical Research Council of Australia (NHMRC). In 
relation to the early origins of obesity, it is particularly 
notable that the World Health Organization has suggested 
that early life is likely to provide the optimal window of 
opportunity for effective strategies for obesity preven-
tion. However, despite the growing recognition of the 
importance of early life nutrition, the translation of these 
findings into public policy and clinical practice remains 
problematic. Part of the reason for this is the complexity of 
the issue – it is relatively simple to implement a zero-tol-
erance policy on cigarettes or alcohol during pregnancy, 
whereas doing the same in nutrition becomes much more 
complex. The issues around food safety during pregnancy 
(e.g., avoidance of listeria) have generally been well pub-
licized, but the importance of other factors in the diet and 
the potential long-term risks associated with inappropri-
ate nutritional choices during pregnancy and lactation 
has perhaps been less effectively communicated. There-
fore, over the next 5–10 years, we hope that clearer and 
Muhlhausler et al.: Maternal overnutrition and metabolic programming      33
more consistent nutritional messages are being effectively 
communicated to the population by clinicians and policy 
makers.
A large part of the problem is the confusion within 
the field itself regarding the key drivers of programming. 
The majority of studies in animal models of maternal 
obesity have focused on the effects of diets containing 
high levels of saturated fats (much higher than those 
that are typically found in human diets), and the mech-
anisms induced by such exposure may not be relevant 
to human diets. In addition, it is becoming increasingly 
apparent that different types of dietary fats (saturates, 
monounsaturates, and PUFA) have different effects on 
the developing fetus/infant and that recommendations to 
simply limit fat intake may not be sufficient (or indeed 
correct). Human diets consist of a mixture of macro and 
micronutrients, and there is a need to determine which 
components of the diet are most important in determin-
ing programming effects. As alluded to above, the effects 
may not be mediated by the nutrients themselves, but be 
secondary to the effects of these nutrients or patterns of 
dietary intake on maternal physiology. There have been 
increasing calls for studies that attempt to study the 
independent and synergistic effects of different macro/
micronutrients in this area. We would, therefore, specu-
late that the next 5–10 years will see more defined studies 
which dissect out the role of different dietary components 
on offspring outcomes and an increased understanding 
of which dietary components play the predominant role 
in metabolic programming. This is clearly important for 
developing clear and consistent dietary guidelines for 
pregnant and lactating women.
In terms of underlying mechanisms, there is increas-
ing interest in the role of epigenetics in a number of pro-
gramming phenomena, including the programming of 
obesity. As the cost of technologies for assessing epige-
netic changes decreases further, we anticipate that this 
will expand further into human studies.
As our understanding of the underlying biological 
mechanisms improves, it will be important to use this 
information to design and test potential strategies for 
mitigating or ameliorating these effects. An increasing 
number of clinical studies have begun to test the effect 
of specific interventions, including limiting gestational 
weight gain, low GI diets, and omega-3 supplementa-
tion, on metabolic outcomes in the offspring [75–77]. 
In the next 5-10 years, as the results of these studies 
emerge, we anticipate and hope that the translation of 
studies of developmental programming to clinical prac-
tice and guidelines for pregnant and lactating women 
will increase and that the practical applications of our 
knowledge of the importance of the early nutritional 
environment for the long-term health of individuals will 
be realized.
Highlights
 – Maternal obesity is associated with an increased risk 
of obesity and metabolic disease in the offspring.
 – The mechanisms involved are still the subject of 
intense investigation, but appear to relate to the 
effects of exposure to an excess nutrient supply 
before birth on the development of key metabolic 
systems.
 – Perinatal overnutrition has been associated with the 
programming of increased lipogenic capacity in fat 
cells of the offspring, which may be the primary event 
underlying the early life origins of obesity.
 – Perinatal overnutrition also results in programming 
of the central neural network for the regulation 
of appetite and reward, which is associated with 
hyperphagia and increased preference for palatable 
foods.
 – The current data suggests that it may be possible 
to limit the impact of these programming effects by 
following a nutritionally balanced diet in postnatal 
life.
 – Importantly, however, individuals exposed to perinatal 
overnutrition retain an increased susceptibility to the 
overconsumption of palatable foods, weight gain, 
and obesity and exhibit an exaggerated response 
to metabolic challenges (e.g., Western-style diets) 
during the postnatal period.
 – The composition of the maternal diet, in particular, 
the fatty acid composition, may have important 
implications for the developmental outcomes of the 
offspring; however, which dietary components are the 
key drivers remains unclear.
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